Marlies Y. Bongers

Prof. Dr. Marlies Y. Bongers


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2021 in BMC Sports Science, Medicine and Rehabilitation
Verified
Journal Article
Open access
PDF file
SVSaskia J. Verhoef
Saskia J. Verhoef
MWMerel C. Wielink
Merel C. Wielink
EAEdwin A. Achterberg
Edwin A. Achterberg
MBMarlies Y. Bongers
Marlies Y. Bongers
SGSimone M. T. A. Goossens
Simone M. T. A. Goossens
Background: It is known that amenorrhea is highly prevalent among female athletes. However, a large percentage of them do not seek help if this complaint occurs. We performed this study to gain more insight into the reasons why female athletes do not seek help when experiencing amenorrhea and how care for these women could be improved. Method: Qualitative focus group research. Female athletes were approached to take part in a focus group. They were asked about the main reasons for not reporting amenorrhea and how care for amenorrhea, in their opinion, would ideally be organised. The women were asked to make a list of their top five reasons for both subjects and discuss this among their peers. Results: According to the participants, the five main reasons for not reporting the amenorrhea were: (1) normalizing of the subject, (2) the absence of menstruation is not perceived as a problem by the athletes themselves, (3) experienced shame and taboo, (4) prioritisation of sports performance, and (5) denial. Factors to improve care around menstrual cycle problems in female athletes were: (1) informing athletes, coaches, trainers and mentors, (2) informing doctors, (3) conducting more research on long-term consequences, (4) breaking the taboo on menstrual problems, and (5) having a multidisciplinary collaboration between different specialisms. Conclusion: By informing athletes, coaches, trainers, and mentors about menstrual cycle problems in athletes, more awareness among those groups can be created. According to the athletes, more research is needed on the long-term consequences of amenorrhea in sports, to enable them to make a better assessment of their possible future health risks. Women experience a taboo on discussing menstrual problems; role models discussing the problem may help in decreasing the taboo. A multidisciplinary collaboration of health care providers may improve care around female athletes with menstrual problems.

5 August 2024 in Fertility and Sterility
Verified
Journal Article
Open access
VVVeerle B. Veth
Veerle B. Veth
AKAnne Keukens
Anne Keukens
ARAnouk Reijs
Anouk Reijs
MBMarlies Y. Bongers
Marlies Y. Bongers
VMVelja Mijatovic
Velja Mijatovic
JMJacques W.M. Maas
Jacques W.M. Maas
Endometriosis is an inflammatory disease, with different forms of expression and a variety of complaints. An endometrioma, an ovarian cyst with endometrium-like lining, is one of the most common expressions of abdominal endometriosis. These endometriomas can, in addition to medical treatment, be treated surgically. After surgery, hormonal therapy is still frequently used, for treatment of endometriosis in general and prevention of recurrence of endometriomas specifically. However, not all women want or can receive postoperative hormonal treatment. It is important for this group to know the risk of anatomical recurrence of ovarian endometrioma after surgery for an endometrioma. To determine the recurrence rate for surgically treated endometrioma, without postoperative hormonal treatment. We performed a systematic literature review and meta-analyses, according to the PRISMA guidelines. MEDLINE, EMBASE, and the Cochrane Library were searched until May 2023. The literature search was limited to women with endometrioma who received surgical treatment without postoperative hormonal treatment. A distinction was made in study design including randomised controlled trials, cohort and retrospective studies. For assessment of risk of bias, the Cochrane Handbook for Systematic Reviews of Interventions and The Risk of Bias in Non-randomized Studies - of interventions assessment tool were used. Outcome measure included in this review is endometrioma recurrence. We screened 5367 articles, of which ninety-seven articles were systematically reviewed and fifty-five included in this systematic review. Twelve of these were randomised controlled trials, eleven prospective cohort studies, and thirty-two retrospective studies. Nine randomised controlled trials (RCT's) were assigned as low risk of bias. For non-RCT's, only three studies had low risk of bias. Data of twenty-three studies were pooled in meta-analyses, performed for follow-up periods of 3, 6, 12 and 24 months. These studies showed a recurrence rate of 4%, 14%, 17% and 27% respectively. The meta-analysis, at 24 months after surgery the endometrioma recurrence rate showed a weighted average up to 27%. With this study, we aimed to determine the recurrence rate of endometrioma after surgical treatment in women without postoperative hormonal treatment use. Recurrence rates were up to 27%.

1 April 2017 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Open access
MLMarike Lemmers
Marike Lemmers
MVMarianne A.C. Verschoor
Marianne A.C. Verschoor
KRKatrien Oude Rengerink
Katrien Oude Rengerink
CNChristiana Naaktgeboren
Christiana Naaktgeboren
PBPatrick M. Bossuyt
Patrick M. Bossuyt
BMBWJ Mol
BWJ Mol
To assess the effectiveness of curettage versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for first trimester miscarriage. We conducted a multicenter cohort study alongside a randomized clinical trial (RCT) between June 2012 until July 2014. 27 Dutch hospitals participated. Women with an incomplete evacuation after misoprostol treatment for first trimester miscarriage who declined to participate in the RCT, received treatment of their preference; curettage (n=65) or expectant management (n=132). A successful outcome was defined as an empty uterus on sonography at six weeks or uneventful clinical follow-up. We furthermore assessed complication rate and (re)intervention rate RESULTS: Of the 197 women who declined to participate in the RCT, 65 preferred curettage and 132 expectant management. A successful outcome was observed in 62/65 women (95%) in the surgical group versus 112/132 women (85%) in the expectant group (RR 1.1, 95% CI 1.03-1.2), with complication rates of 6.2% versus 2.3%, respectively (RR 2.7, 95% CI 0.6-12). In women with an incomplete evacuation of the uterus after misoprostol treatment, expectant management is an effective and safe option. This finding could restrain the use of curettage in women that have used misoprostol in the treatment of first trimester miscarriage.

13 April 2023 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Open access
NCNatalie A. M. Cooper
Natalie A. M. Cooper
CRCarol Rivas
Carol Rivas
MMMalcolm G. Munro
Malcolm G. Munro
HCHilary O. D. Critchley
Hilary O. D. Critchley
TCThomas Justin Clark
Thomas Justin Clark
Khalid KhanKhalid Khan
Khalid Khan
Objective: To develop a core outcome set for heavy menstrual bleeding (HMB).Design: Core outcome set (COS) development methodology described by the COMET initiative.Setting: University hospital gynaecology department, online international survey and web‐based international consensus meetings.Population or sample: An international collaboration of stakeholders (clinicians, patients, academics, guideline developers) from 20 countries and 6 continents.Methods: Phase 1: Systematic review of previously reported outcomes to identify potential core outcomes. Phase 2: Qualitative studies with patients to identify outcomes most important to them. Phase 3: Online two‐round Delphi survey to achieve consensus about which outcomes are most important. Phase 4: A consensus meeting to finalise the COS.Main outcome measures: Outcome importance was assessed in the Delphi survey on a 9‐point scale.Results: From the ‘long list’ of 114, 10 outcomes were included in the final COS: subjective blood loss; flooding; menstrual cycle metrics; severity of dysmenorrhoea; number of days with dysmenorrhoea; quality of life; adverse events; patient satisfaction; number of patients going on to have further treatment for HMB and haemoglobin level.Conclusions: The final COS includes variables that are feasible for use in clinical trials in all resource settings and apply to all known underlying causes of the symptom of HMB. These outcomes should be reported in all future trials of interventions, their systematic reviews, and clinical guidelines to underpin policy.

19 December 2014 in International Urogynecology Journal
Verified
Journal Article
Closed access
PDF file
MIMèlanie N. Van Ijsselmuiden
Mèlanie N. Van Ijsselmuiden
MKManon Heleen Kerkhof
Manon Heleen Kerkhof
RSRené P. Schellart
René P. Schellart
MBMarlies Y. Bongers
Marlies Y. Bongers
WSWilbert A. Spaans
Wilbert A. Spaans
HEHugo W. F. Van Eijndhoven
Hugo W. F. Van Eijndhoven

30 January 2024 in European Journal of Sport Science
Verified
Journal Article
Open access
SVSaskia J. Verhoef
Saskia J. Verhoef
MWMerel C. Wielink
Merel C. Wielink
EAEdwin A. Achterberg
Edwin A. Achterberg
MBMarlies Y. Bongers
Marlies Y. Bongers
SGSimone M. T. A. Goossens
Simone M. T. A. Goossens
Relative energy deficiency in sport (RED‐S) refers to an impaired physiological functioning caused by low energy availability in both male and female athletes. It may affect many physiological processes, causing, among others, stress fractures and disturbed menstrual cycles. Athletes may present these symptoms to different health care workers. The purpose of this research was to investigate the awareness and knowledge of physiotherapists, general practitioners, gynaecologists, sports physicians and orthopaedic surgeons on RED‐S. An online questionnaire on awareness and knowledge of RED‐S was developed for the above‐mentioned health experts. A total number of 799 respondents were included for analysis, and 22.0% of the respondents had heard of the existence of RED‐S. The highest percentage was reported by sports physicians (92.9%) and the lowest among general practitioners (10.1%). Sports physicians scored highest on knowledge questions about RED‐S with a mean score of 8.9, and physiotherapists scored lowest with a mean score of 5.7. Of all respondents, 57.6% reported feeling competent discussing possible underlying problems of RED‐S and 7.4% felt qualified treating RED‐S. Of the responding gynaecologists, 46.6% would suggest starting oral contraception when presented a patient with symptoms of RED‐S, thereby only masking the symptoms of amenorrhoea but not treating the underlying cause: a low energy availability. This research reports a low awareness and knowledge among participating physiotherapists, general practitioners, gynaecologists and orthopaedic surgeons on RED‐S. Therefore, further education for these specialists on this topic is needed, since most athletes will initially consult these health care providers first.